Form 4: Vir Biotechnology EVP and General Counsel Sells Shares Acquired Through Employee Stock Purchase Program
SEC Form 4 Filing
Vanina de Verneuil, EVP and General Counsel of Vir Biotechnology, sold 76 shares of common stock acquired through the company's employee stock purchase program.
Summary
- Vanina de Verneuil, an Executive Vice President and General Counsel at Vir Biotechnology, sold 76 shares of the company's common stock on December 2, 2024.
- The shares were sold at a price of $8.2201 per share.
- These shares were acquired through the company's employee stock purchase program on November 29, 2024.
- The sale was executed automatically six months after a sale instruction was entered on May 28, 2024.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction related to an employee stock purchase program, with no indication of positive or negative sentiment.
Industry Context
This is a routine transaction related to an employee stock purchase program and is common for executives at publicly traded companies.
Comparison to Industry Standards
- Employee stock purchase programs are a common benefit offered by many publicly traded companies, including those in the biotechnology sector.
- The automatic sale of shares after a set period is a typical feature of these programs to ensure compliance with insider trading regulations.
- Similar transactions are regularly reported by executives at comparable companies.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it involves a small number of shares and is part of a routine employee program.
Key Dates
| Date | Description |
|---|---|
| 2024-05-28 | Date of sale instruction entered for shares purchased through the employee stock purchase program. |
| 2024-11-29 | Date of acquisition of 76 shares of common stock through the employee stock purchase program. |
| 2024-12-02 | Date of sale of 76 shares of common stock. |
| 2024-12-04 | Date of filing of the SEC Form 4. |
Keywords
Vir Biotechnology, insider trading, stock sale, employee stock purchase program, Vanina de Verneuil, SEC Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.